Acne Therapeutics Market Report and Forecast 2024-2032

Acne Therapeutics Market Report and Forecast 2024-2032


Acne Therapeutics Market Report and Forecast 2024-2032

Acne Therapeutics Market Outlook

The acne therapeutics market was valued at USD 7.7 billion in 2023, driven by increased research activities in OTC drugs. The market size is anticipated to grow at a CAGR of 4.6% during the forecast period of 2024-2032.

Acne: Introduction

Acne is a common skin condition that occurs when hair follicles become clogged with oil and dead skin cells. It typically manifests as pimples, blackheads, or whiteheads, primarily on the face, forehead, chest, upper back, and shoulders. Acne is most prevalent during puberty due to hormonal changes but can affect people of all ages. Various treatments, including over-the-counter creams, prescription medications, and lifestyle changes, can help manage acne. Severe cases may require dermatological intervention.

Key Trends in the Acne Therapeutics Market

There's a growing trend towards using combination therapies that employ multiple agents to target different causes of acne, such as bacteria, inflammation, and clogged pores. These combinations often include topical retinoids, antibiotics, and benzoyl peroxide.

Innovation in topical treatments continues, with new formulations designed to reduce side effects and increase effectiveness. This includes better delivery systems for active ingredients and the development of new retinoids.

Consumers are increasingly seeking natural and organic skincare products, including those for acne treatment. This trend is driven by a growing awareness of the potential side effects of synthetic chemicals and a desire for safer, more sustainable options.

Personalized treatment plans based on individual skin types, acne severity, and response to previous treatments are becoming more common. This approach aims to optimize treatment efficacy and reduce side effects.

The availability of over-the-counter acne treatments is expanding, with more products that used to be prescription-only now accessible without a prescription.

There's an ongoing focus on understanding the underlying mechanisms of acne, which is leading to the development of new treatment targets and therapeutic strategies.

The use of technology, including light therapy and laser treatments, is growing. These devices offer alternative options for acne treatment, particularly for cases resistant to conventional therapies. Increased awareness about acne and its proper management, driven by educational campaigns and greater online access to health information, is helping to reduce stigma and encourage early treatment.

Acne Therapeutics Market Segmentation

Market breakup by Acne Type
  • Complete Acne Therapeutics
  • Incomplete Acne Therapeutic
Market breakup by Treatment Type
  • Retinoid
  • Antibiotics
  • Hormonal Agents
  • Anti-inflammatory
Market breakup by End User
  • Hospital
  • Clinics
  • Others
Market Breakup by Region
  • United States
  • EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
Acne Therapeutics Market Overview

In North America, the United States has been a dominant player in the acne therapeutics market. The high prevalence of acne, coupled with a strong emphasis on aesthetics and the availability of advanced healthcare infrastructure, has contributed to robust market growth. The U.S. market has also seen a trend toward the adoption of combination therapies and a growing preference for prescription treatments over OTC products.

Europe has a significant market share, driven by awareness about acne treatments and substantial healthcare spending. Western European countries have shown a strong preference for evidence-based therapeutic regimens. There's also a growing interest in dermocosmetic products that combine cosmetic and therapeutic benefits.

Japan region is rapidly growing, driven by increasing awareness of acne treatments, rising disposable incomes, and improving healthcare infrastructure.Acne Therapeutics Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Cipher Pharmaceuticals
  • GlaxoSmithKline PLC
  • L'Oréal S.A. (La Roche-Posay Laboratoire Dermatologique)
  • Teva Pharmaceutical
  • Sun Pharmaceuticals
  • Abbvie Inc
  • F. Hoffmann-la Roche
  • Viatris Inc.
  • Johnson & Johnson
  • Bausch Health Companies Inc.
  • Perricone MD
  • Glow Biotics LLC
  • Revision Skincare
  • The Beauty Health Company
  • PHYTOMER
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Acne Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Acne Epidemiology Analysis – Seven Major Markets
5.1 7MM Epidemiology Scenario Overview (2017-2032)
5.2 United States Acne Epidemiology Forecast (2017-2032)
5.3 EU-4 and United Kingdom Acne Epidemiology Forecast (2017-2032)
5.3.1 Germany Acne Epidemiology Forecast (2017-2032)
5.3.2 France Acne Epidemiology Forecast (2017-2032)
5.3.3 Italy Acne Epidemiology Forecast (2017-2032)
5.3.4 Spain Acne Epidemiology Forecast (2017-2032)
5.3.5 United Kingdom Acne Epidemiology Forecast (2017-2032)
5.4 Japan Acne Epidemiology Forecast (2017-2032)
6 Acne Therapeutics Market Overview – 7MM
6.1 Acne Therapeutics Market Historical Value (2017-2023)
6.2 Acne Therapeutics Market Forecast Value (2024-2032)
7 Acne Therapeutics Market Landscape – 7MM
7.1 Acne Therapeutics: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Acne Therapeutics: Product Landscape
7.2.1 Analysis by Injury Type
7.2.2 Analysis by Route of Administration
8 Acne Therapeutics Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Acne Therapeutics Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Acne Therapeutics Market Segmentation – Seven Major Markets
11.1 Acne Therapeutics Market by Injury Type
11.1.1 Market Overview
11.1.2 Complete Acne Therapeutics
11.1.3 Incomplete Acne Therapeutics
11.2 Acne Therapeutics Market by Treatment Type
11.2.1 Market Overview
11.2.2 Therapeutics
11.2.2.1 Retinoid
11.2.2.2 Antibiotics
11.2.2.3 Hormonal Agents
11.2.2.4 Anti-inflammatory
11.2.2.5 Other Agents
11.2.3 Other Treatments
11.3 Acne Therapeutics Market by Route of Administration
11.3.1 Market Overview
11.3.2 Oral
11.3.3 Topical
11.3.4 Others
11.4 Acne Therapeutics Market by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Clinics
11.4.4 Others
11.5 Acne Therapeutics Market by Region
11.5.1 Market Overview
11.5.2 United States
11.5.3 EU-4 and the United Kingdom
11.5.3.1 Germany
11.5.3.2 France
11.5.3.3 Italy
11.5.3.4 Spain
11.5.3.5 United Kingdom
11.6 Japan
12 United States Acne Therapeutics Market
12.1 Acne Therapeutics Market Historical Value (2017-2023)
12.2 Acne Therapeutics Market Forecast Value (2024-2032)
12.2.1 Acne Therapeutics Market by Injury Type
12.2.2 Acne Therapeutics Market by Treatment Type
13 EU-4 and United Kingdom Acne Therapeutics Market
13.1 Acne Therapeutics Market Historical Value (2017-2023)
13.2 Acne Therapeutics Market Forecast Value (2024-2032)
13.3 Germany Acne Therapeutics Market Overview
13.3.1 Acne Therapeutics Market by Injury Type
13.3.2 Acne Therapeutics Market by Treatment Type
13.4 France Acne Therapeutics Market Overview
13.4.1 Acne Therapeutics Market by Injury Type
13.4.2 Acne Therapeutics Market by Treatment Type
13.5 Italy Acne Therapeutics Market Overview
13.5.1 Acne Therapeutics Market by Injury Type
13.5.2 Acne Therapeutics Market by Treatment Type
13.6 Spain Acne Therapeutics Market Overview
13.6.1 Acne Therapeutics Market by Injury Type
13.6.2 Acne Therapeutics Market by Treatment Type
13.7 United Kingdom Acne Therapeutics Market Overview
13.7.1 Acne Therapeutics Market by Injury Type
13.7.2 Acne Therapeutics Market by Treatment Type
14 Japan Acne Therapeutics Market
14.1 Acne Therapeutics Market Historical Value (2017-2023)
14.2 Acne Therapeutics Market Forecast Value (2024-2032)
14.1.1 Acne Therapeutics Market by Injury Type
14.1.2 Acne Therapeutics Market by Treatment Type
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 INDIA CDSCO
15.1.4 JAPAN PMDA
15.1.5 Others
16 Patent Analysis
16.1 Analysis by Type of Patent
16.2 Analysis by Publication year
16.3 Analysis by Issuing Authority
16.4 Analysis by Patent Age
16.5 Analysis by CPC Analysis
16.6 Analysis by Patent Valuation
16.7 Analysis by Key Players
17 Grants Analysis
17.1 Analysis by year
17.2 Analysis by Amount Awarded
17.3 Analysis by Issuing Authority
17.4 Analysis by Grant Application
17.5 Analysis by Funding Institute
17.6 Analysis by NIH Departments
17.7 Analysis by Recipient Organization
18 Clinical Trials Analysis
18.1 Analysis by Trial Registration Year
18.2 Analysis by Trial Status
18.3 Analysis by Trial Phase
18.4 Analysis by Therapeutic Area
18.5 Analysis by Geography
19 Funding and Investment Analysis
19.1 Analysis by Funding Instances
19.2 Analysis by Type of Funding
19.3 Analysis by Funding Amount
19.4 Analysis by Leading Players
19.5 Analysis by Leading Investors
19.6 Analysis by Geography
20 Partnership and Collaborations Analysis
20.1 Analysis by Partnership Instances
20.2 Analysis by Type of Partnership
20.3 Analysis by Leading Players
20.4 Analysis by Geography
21 Supplier Landscape
21.1 Cipher Pharmaceuticals
21.1.1 Financial Analysis
21.1.2 Product Portfolio
21.1.3 Demographic Reach and Achievements
21.1.4 Mergers and Acquisitions
21.1.5 Certifications
21.2 GlaxoSmithKline PLC
21.2.1 Financial Analysis
21.2.2 Product Portfolio
21.2.3 Demographic Reach and Achievements
21.2.4 Mergers and Acquisitions
21.2.5 Certifications
21.3 L'Oréal S.A. (La Roche-Posay Laboratoire Dermatologique)
21.3.1 Financial Analysis
21.3.2 Product Portfolio
21.3.3 Demographic Reach and Achievements
21.3.4 Mergers and Acquisitions
21.3.5 Certifications
21.4 Teva Pharmaceuticals
21.4.1 Financial Analysis
21.4.2 Product Portfolio
21.4.3 Demographic Reach and Achievements
21.4.4 Mergers and Acquisitions
21.4.5 Certifications
21.5 Sun Pharmaceuticals
21.5.1 Financial Analysis
21.5.2 Product Portfolio
21.5.3 Demographic Reach and Achievements
21.5.4 Mergers and Acquisitions
21.5.5 Certifications
21.6 Abbvie Inc.
21.6.1 Financial Analysis
21.6.2 Product Portfolio
21.6.3 Demographic Reach and Achievements
21.6.4 Mergers and Acquisitions
21.6.5 Certifications
21.7 F. Hoffmann-la Roche Ltd
21.7.1 Financial Analysis
21.7.2 Product Portfolio
21.7.3 Demographic Reach and Achievements
21.7.4 Mergers and Acquisitions
21.7.5 Certifications
21.8 Viatris Inc.
21.8.1 Financial Analysis
21.8.2 Product Portfolio
21.8.3 Demographic Reach and Achievements
21.8.4 Mergers and Acquisitions
21.8.5 Certifications
21.9 Johnson & Johnson
21.9.1 Financial Analysis
21.9.2 Product Portfolio
21.9.3 Demographic Reach and Achievements
21.9.4 Mergers and Acquisitions
21.9.5 Certifications
21.10 Bausch Health Companies Inc.
21.10.1 Financial Analysis
21.10.2 Product Portfolio
21.10.3 Demographic Reach and Achievements
21.10.4 Mergers and Acquisitions
21.10.5 Certifications
21.11 Perricone MD
21.11.1 Financial Analysis
21.11.2 Product Portfolio
21.11.3 Demographic Reach and Achievements
21.11.4 Mergers and Acquisitions
21.11.5 Certifications
21.12 Glow Biotics LLC
21.12.1 Financial Analysis
21.12.2 Product Portfolio
21.12.3 Demographic Reach and Achievements
21.12.4 Mergers and Acquisitions
21.12.5 Certifications
21.13 Revision Skincare
21.13.1 Financial Analysis
21.13.2 Product Portfolio
21.13.3 Demographic Reach and Achievements
21.13.4 Mergers and Acquisitions
21.13.5 Certifications
21.14 The Beauty Health Company
21.14.1 Financial Analysis
21.14.2 Product Portfolio
21.14.3 Demographic Reach and Achievements
21.14.4 Mergers and Acquisitions
21.14.5 Certifications
21.15 PHYTOMER
21.15.1 Financial Analysis
21.15.2 Product Portfolio
21.15.3 Demographic Reach and Achievements
21.15.4 Mergers and Acquisitions
21.15.5 Certifications
22 Acne Therapeutics - Distribution Model (Additional Insight)
22.1 Overview
22.2 Potential Distributors
22.3 Key Parameters for Distribution Partner Assessment
23 Key Opinion Leaders (KOL) Insights (Additional Insight)
24 Company Competitiveness Analysis (Additional Insight)
24.1 Very Small Companies
24.2 Small Companies
24.3 Mid-Sized Companies
24.4 Large Companies
24.5 Very Large Companies
25 Payment Methods (Additional Insight)
25.1 Government Funded
25.2 Private Insurance
25.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings